Axogen Inc AXGN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
Axogen, Inc. Reports Third Quarter 2026 Financial Results
Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026
Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference
Trading Information
- Previous Close Price
- $55.40
- Day Range
- $55.01–57.46
- 52-Week Range
- $23.28–59.72
- Bid/Ask
- $49.60 / $64.20
- Shares Outstanding
- 59.73M
- Market Cap
- $3.34B
- Volume/Avg
- 1M / 2M
Key Statistics
- Price/Earnings (Normalized)
- 1,338.42
- Price/Sales
- 10.83
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 622
- Website
- https://www.axogeninc.com
Valuation
Metric | AXGN |
|---|---|
Price/Earnings (Normalized) | 1,338.42 |
Price/Book Value | 6.73 |
Price/Sales | 10.83 |
Price/Cash Flow | 77.15 |
Price/Earnings
AXGN
Financial Strength
Metric | AXGN |
|---|---|
Quick Ratio | 10.48 |
Current Ratio | 12.02 |
Interest Coverage | −12.22 |
Quick Ratio
AXGN
Profitability
Metric | AXGN |
|---|---|
Return on Assets (Normalized) | 8.82% |
Return on Equity (Normalized) | 11.19% |
Return on Invested Capital (Normalized) | 10.51% |
Return on Assets
AXGN
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|Q?Wm#%b | LOCK|%zGk^ | $188B | |||
| Medtronic PLC MDT | LOCK|m?%%&@? | LOCK|&m?%# | $132B | |||
| Stryker Corp SYK | LOCK|pXC>G># | LOCK|JMB | $118B | |||
| Boston Scientific Corp BSX | LOCK|m$?#kj | LOCK|BtjDL | $64B | |||
| Edwards Lifesciences Corp EW | LOCK|^<WtjDN | LOCK|p@Zl | $62B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|XP<h^sL | LOCK|#g | $38B | |||
| DexCom Inc DXCM | LOCK|dPQy^q?Z | LOCK|<&QpR | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|TL | LOCK|^nZ | $30B | |||
| Steris PLC STE | LOCK|>s&JcSy | LOCK|X&wt | $26B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|f<<d?!GH | LOCK|&L! | $20B |
United States